Pharmacokinetics study of a supersaturatable self-microemulsifying drug delivery system for ellagic acid by UHPLC-Q-TOF-MS

1. G. Quan, B. Niu, V. Singh, Y. Zhou, C. Wu, X. Pan and C. Wu, Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement, Int. J. Nanomed.12 (2017) 8801–8811; https://doi.org/10.2147/IJN.S14971710.2147/IJN.S149717Search in Google Scholar

2. N. T. Tung, C. S. Tran, H. A. Nguyen, T. D. Nguyen, S. C. Chi, D. V. Pham, Q. D. Bui and X. H. Ho, Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin, Int. J. Pharm.555 (2019) 63–76; https://doi.org/10.1016/j.ijpharm.2018.11.03610.1016/j.ijpharm.2018.11.036Search in Google Scholar

3. Z. Q. Chen, Y. Liu, J. H. Zhao, L. Wang and N. P. Feng, Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system, Int. J. Nanomed.7 (2012) 1115–1125; https://doi.org/10.2147/IJN.S2876110.2147/IJN.S28761Search in Google Scholar

4. J. M. Landete, Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health, Food Res. Int.44 (2011) 1150–1160; https://doi.org/10.1016/j.foodres.2011.04.02710.1016/j.foodres.2011.04.027Search in Google Scholar

5. F. Lei, D. M. Xing, L. Xiang, Y. N. Zhao, W. Wang, L. J. Zhang and L. J. Du, Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract, J. Chromatogr. B796 (2003) 189–194; https://doi.org/10.1016/S1570-0232(03)00610-X10.1016/S1570-0232(03)00610-XSearch in Google Scholar

6. A. W. R. Hamad, W. M. Al-Momani, S. Janakat and S. A. Oran, Bioavailability of ellagic acid after single dose administration using HPLC, Par. J. Stat.8 (2009) 1661–1664; https://DOI:10.3923/pjn.2009.1661.166410.3923/pjn.2009.1661.1664Search in Google Scholar

7. L. Yan, P. Yin, C. Ma and Y. Liu, Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), Molecules19 (2014) 18923–18935; https://doi:10.3390/molecules19111892310.3390/molecules191118923627145925412040Search in Google Scholar

8. J. Wang, D. Zheng, Y. Wang, C. Zhang and X. Sun, Pharmacokinetics study of Erhuang decoction extracts in rats by HPLC-MS/MS, J. Chromatogr. B1059 (2017) 35–42; https://doi.org/10.1016/j.jchromb.2017.05.01910.1016/j.jchromb.2017.05.01928570935Search in Google Scholar

9. G. R. Valicherla, M. Riyazuddin, S. Shahi, A. P. Gupta, A. A. Syed, A. Husain and J. R. Gayen, LCESI-MS/MS assay development and validation of a novel antidiabetic peptide PSTi8 in mice plasma using SPE: An application to pharmacokinetics, J. Pharm. Biomed. Anal.180 (2019) 113074; https://doi.org/10.1016/j.jpba.2019.11307410.1016/j.jpba.2019.11307431891874Search in Google Scholar

10. V. Ferrone, M. Carlucci, P. Palumbo and G. Carlucci, Bioanalytical method development for quantification of ulifloxacin, fenbufen and felbinac in rat plasma by solid-phase extraction (SPE) and HPLC with PDA detection, J. Pharm. Biomed. Anal.123 (2016) 205–212; https://doi.org/10.1016/j.jpba.2016.01.06210.1016/j.jpba.2016.01.06226898973Search in Google Scholar

11. D. Zheng, C. Lv, X. Sun, J. Wang and Z. Zhao, Preparation of a supersaturatable self-microemulsion as drug delivery system for ellagic acid and evaluation of its antioxidant activities, J. Drug Deliv. Sci. Technol.53 (2019) 101209; https://doi.org/10.1016/j.jddst.2019.10120910.1016/j.jddst.2019.101209Search in Google Scholar

12. G. Z. Pei, W. Chen, H. Zhang and G. H. Li, Pharmacokinetics of ellagic acid tablets in rabbits, Chin. J. Exp. Tradit. Med. Formulae18 (2012) 136–138; https://doi.org/10.13422/j.cnki.syfjx.2012.12.047Search in Google Scholar

13. C. Sun, Y. Gui, R. Hu, J. Chen, B. Wang, Y. Guo, W. Lu, X. Nie, Q. Shen, S. Gao and W. Fang, Preparation and Pharmacokinetics Evaluation of Solid Self-Microemulsifying Drug Delivery System (SSMEDDS) of Osthole, AAPS PharmSciTech19 (2018) 2301–2310; https://doi.org/10.1208/s12249-018-1067-310.1208/s12249-018-1067-329845504Search in Google Scholar

14. J. Jinno, N. Kamada, M. Miyake, K. Yamada, T. Mukai, M. Odomi, H. Toguchi, G. G. Liversidge, K. Higaki and T. Kimura, Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs, J. Controll. Release111 (2006) 56–64; https://doi.org/10.1016/j.jconrel.2005.11.01310.1016/j.jconrel.2005.11.01316410029Search in Google Scholar

15. H. Mu, R. Holm and A. Müllertz, Lipid-based formulations for oral administration of poorly water-soluble drugs, Int. J. Pharm.453 (2013) 215–224; https://doi.org/10.1016/j.ijpharm.2013.03.05410.1016/j.ijpharm.2013.03.05423578826Search in Google Scholar